Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Adamis Pharmaceuticals Corporation
(OP:
ADMP
)
0.7000
USD
+0.0200 (+2.94%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
108,813
Open
0.6930
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.6800
Today's Range
0.6900 - 0.7200
52wk Range
0.3400 - 1.090
Shares Outstanding
104,427,992
Dividend Yield
N/A
Top News
More News
Adamis Pharmaceuticals CEO Provides Update for Shareholders
May 03, 2013
category
SCIENCE
,
Advisory
,
PHARMACEUTICALS
, and 4 more.
from
Latest eTeligis Press Releases with 'Plus' ranking
Adamis Pharmaceuticals CEO Provides Update for Shareholders
May 03, 2013
from
PR Newswire
More News
Read More
Adamis Pharmaceuticals Prevails in License Dispute Litigation
February 28, 2013
category
LEGAL
,
Law & Legal Issues
,
Company Announcement
, and 1 more.
from
Latest eTeligis Press Releases with 'Plus' ranking
Adamis Pharmaceuticals Prevails in License Dispute Litigation
February 28, 2013
from
PR Newswire
Adamis Prostate Cancer Drug APC-100 Receives Allowance for Patent in Canada
November 03, 2011
from
Business Wire News Releases
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Adamis Pharmaceuticals Corp.
October 27, 2011
from
Business Wire News Releases
Adamis Prostate Cancer Drug APC-200 Granted Patents in Singapore and South Africa
September 22, 2011
from
Business Wire News Releases
Adamis Pharmaceuticals Begins Prostate Cancer Trial
August 30, 2011
from
Business Wire News Releases
Adamis Receives Another Milestone Payment
July 26, 2011
from
Business Wire News Releases
Adamis Prostate Cancer Drug APC-100 Granted a Patent in US
July 21, 2011
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here